Targeted therapy: An elusive cancer target.
Carolyn
C
Brown
D020533:Angiogenesis Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols; D002292:Carcinoma, Renal Cell / Q000098:blood supply / Q000188:drug therapy / Q000235:genetics / Q000276:immunology; D002986:Clinical Trials as Topic; D006801:Humans; D007167:Immunotherapy; D007680:Kidney Neoplasms / Q000098:blood supply / Q000188:drug therapy* / Q000235:genetics / Q000276:immunology; D058990:Molecular Targeted Therapy / Q000009:adverse effects; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy / Q000276:immunology / Q000473:pathology / Q000517:prevention & control; D009389:Neovascularization, Pathologic / Q000188:drug therapy / Q000201:enzymology / Q000235:genetics / Q000517:prevention & control; D016019:Survival Analysis; D016896:Treatment Outcome
D020533:Angiogenesis Inhibitors